356 related articles for article (PubMed ID: 29925744)
1. Effect of lipoprotein-associated phospholipase A2 inhibitor on insulin resistance in streptozotocin-induced diabetic pregnant rats.
Wang GH; Jin J; Sun LZ
Endocr J; 2018 Sep; 65(9):903-913. PubMed ID: 29925744
[TBL] [Abstract][Full Text] [Related]
2. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
[TBL] [Abstract][Full Text] [Related]
3. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
[TBL] [Abstract][Full Text] [Related]
4. [Influence of tert-butylhydroquinone on the islets function and expression of HO-1 and VEGF in retina of type 2 diabetic rats].
Zhang S; Tian M; Li J; Han P; Huang Q; Lyu H
Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):373-81. PubMed ID: 27220712
[TBL] [Abstract][Full Text] [Related]
5. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
Zeng CJ; Zhang L; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
[TBL] [Abstract][Full Text] [Related]
6. Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.
Lv SL; Zeng ZF; Gan WQ; Wang WQ; Li TG; Hou YF; Yan Z; Zhang RX; Yang M
Acta Pharmacol Sin; 2021 Dec; 42(12):2016-2032. PubMed ID: 34226664
[TBL] [Abstract][Full Text] [Related]
7. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
[TBL] [Abstract][Full Text] [Related]
8. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice.
Hu MM; Zhang J; Wang WY; Wu WY; Ma YL; Chen WH; Wang YP
Acta Pharmacol Sin; 2011 Oct; 32(10):1253-8. PubMed ID: 21970837
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
[TBL] [Abstract][Full Text] [Related]
12. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
Singh J; Kakkar P
Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466
[TBL] [Abstract][Full Text] [Related]
13. MiR-21 antagomir improves insulin resistance and lipid metabolism disorder in streptozotocin-induced type 2 diabetes mellitus rats.
Wang Y; Yang LZ; Yang DG; Zhang QY; Deng ZN; Wang K; Mao XJ
Ann Palliat Med; 2020 Mar; 9(2):394-404. PubMed ID: 32233625
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A
Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L
Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128
[TBL] [Abstract][Full Text] [Related]
15. [Adipocyte insulin binding and glucose transport in normal pregnancy and streptozotocin-induced diabetic pregnancy in the rat: evidence for a postreceptor abnormality in insulin action].
Shimizu K; Toyoda N; Morikawa F; Sugiyama Y
Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1894-904. PubMed ID: 6687055
[TBL] [Abstract][Full Text] [Related]
16. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA
Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG
Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218
[TBL] [Abstract][Full Text] [Related]
17. Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease.
Riley RF; Corson MA
IDrugs; 2009 Oct; 12(10):648-55. PubMed ID: 19790016
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance.
Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP
Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963
[TBL] [Abstract][Full Text] [Related]
19. Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
Johnson JL; Shi Y; Snipes R; Janmohamed S; Rolfe TE; Davis B; Postle A; Macphee CH
PLoS One; 2014; 9(2):e89034. PubMed ID: 24586490
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
Wilensky RL; Shi Y; Mohler ER; Hamamdzic D; Burgert ME; Li J; Postle A; Fenning RS; Bollinger JG; Hoffman BE; Pelchovitz DJ; Yang J; Mirabile RC; Webb CL; Zhang L; Zhang P; Gelb MH; Walker MC; Zalewski A; Macphee CH
Nat Med; 2008 Oct; 14(10):1059-66. PubMed ID: 18806801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]